What if a single federal policy could have prevented 11,000 premature deaths, saved Canada nearly $92 billion in systemic health costs, and cut 362 megatonnes of carbon and related air pollution? Those benefits were within reach. With the repeal of the Electric Vehicle Availability Standard (EVAS), they are no longer guaranteed.
EVAS was never just a climate policy. It was a health policy—one designed to reduce the fine particulate matter and nitrogen oxides that show up in emergency room visits, in missed workdays, the loss of loved ones, and in the day to day lives of families across the country. Transportation pollution remains one of the largest contributors to poor air quality in Canada, and the health consequences are both measurable and preventable.
Now that EVAS is gone, the question is, what comes next? And will Canada put in place new rules strong enough to deliver the same health and climate outcomes EVAS would have secured?
Under the original EVAS timeline—20% EV sales by 2026, 60% by 2030, and 100% by 2035—Canada would have prevented 11,000 premature deaths and delivered $91.9 billion in cumulative health benefits. These outcomes were tied directly to mandatory EV supply requirements. Without those requirements, the benefits evaporate.
The federal government has replaced EVAS with scant details around performance‑based GHG standards for model years 2027–2032, paired with consumer rebates and charging investments. These measures may improve affordability and expand choice, but they do not guarantee that enough zero‑emission vehicles will reach or even be available to the Canadian market—especially in provinces without sales mandates. Officials have confirmed they have not modeled the pollution‑reduction impact of the new standards, leaving Canadians without clarity on whether the replacement policy can match the avoided deaths, reduced emissions, and long‑term economic gains EVAS would have delivered.
If Canada is serious about protecting public health and meeting its climate goals, not to mention its economic competitiveness in this booming global market, the next generation of policy must be designed to replace what EVAS would have achieved—not simply gesture in its direction.
That means adopting national GHG standards strong enough to ensure rapid electrification, and aligning those standards with the European Union rather than the United States, whose rules have failed to produce meaningful reductions from tailpipe emissions since 1990. Canada also needs a regulatory framework that guarantees EV availability in every province, not just those with their own mandates. Without clear supply requirements, automakers will continue prioritizing markets with stronger rules, leaving many Canadians waiting for vehicles that will never arrive and will miss out on the time limited incentives.
Policy certainty is equally essential. Investors in charging infrastructure need stable, predictable rules to guide long‑term decisions. The repeal of EVAS has created a vacuum at precisely the moment when Canada needs clarity. Without it, charging deployment will slow, and the country risks falling further behind global competitors.
Health Canada’s “benefits per tonne” method makes the stakes clear: every tonne of pollution removed reduces illness, hospital visits, chronic disease, and premature death. EVAS would have removed millions of tonnes of harmful pollutants. The health outcomes are not abstract. They are measurable, immediate, and economically significant. Cleaner air means fewer hospital visits, longer lives, and billions saved in public and private health costs. Canada has lost the certainty and scale of benefits EVAS would have delivered. But the need for those benefits has not changed. The federal government now has a responsibility to put forward a policy package—rooted in strong GHG standards, EU alignment (decoupled from America), and guaranteed EV supply—that can match the avoided deaths, reduced emissions, and economic gains EVAS promised.
The choice is no longer between EVAS and something else. The choice is between policies that protect Canadians’ health and policies that fall short. Canada must choose the former.